Elsevier

Clinical Therapeutics

Volume 21, Issue 6, June 1999, Pages 1074-1090
Clinical Therapeutics

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

https://doi.org/10.1016/S0149-2918(99)80026-5Get rights and content

Abstract

Researchers and clinicians have used numerous methods in their attempts to adequately assess patient compliance (adherence) with medication regimens and to identify noncompliant patients. Large variations have been reported in the extent of noncompliance in individual patients and large populations. In addition, nonadherence has often been poorly defined. Direct measures of adherence include drug assays of blood or urine, use of drug markers with the target medication, and direct observation of the patient receiving the medication. Indirect measures of adherence imply that the medication has been used by the patient; these measures include various forms of selfreporting by the patient, medication measurement (pill count), use of electronic monitoring devices, and review of prescription records and claims. Compliance measures should be assessed on the basis of their validity (sensitivity and specificity or statistical correlation) and the reference standard used. Many early studies used pill counts as a reference standard, but electronic monitoring devices such as the Medication Event Monitoring System have replaced pill counts as the reference standard. The choice of a method for measuring adherence to a medication regimen should be based on the usefulness and reliability of the method in light of the researcher's or clinician's goals. Specific methods may be more applicable to certain situations, depending on the type of adherence being assessed, the precision required, and the intended application of the results.

References (61)

  • GreenbergRN

    Overview of patient compliance with medication dosing: A literature review

    Clin Ther

    (1984)
  • RogersPG et al.

    Prescription medicine compliance: A review of the baseline of knowledge

  • GrymonpreRE et al.

    Pill count, selfreport, and pharmacy claims data to measure medication adherence in the elderly

    Ann Pharmacother

    (1998)
  • HurleyFL

    Statistical approach to subgroup analyses: Patient compliance data and clinical outcomes

  • GallagherEJ et al.

    The relationship of treatment adherence to the risk of death after myocardial infarction in women

    JAMA

    (1993)
  • HasfordJ

    Biometric issues in measuring and analyzing partial compliance in clinical trials

  • PotterLS

    Oral contraceptive compliance and its role in the effectiveness of the method

  • AndradeSE et al.

    Discontinuation of antihyperlipidemic drugs—do rates reported in clinical trials reflect rates in primary care settings?

    NEJM

    (1995)
  • GibaldiM

    Compliance in clinical trials

    Pharmaceutical News

    (1996)
  • Cramer JA et al.

    Monitoring compliance with antiepileptic drug therapy

  • RansohoffDF et al.

    Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

    NEJM

    (1978)
  • HaynesRB et al.

    Can simple clinical measurements detect patient noncompliance?

    Hypertension

    (1980)
  • MatsuiD et al.

    Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator

    J Clin Pharmacol

    (1994)
  • CraigHM

    Accuracy of indirect measures of medication compliance in hypertension

    Res Nurs Health

    (1985)
  • PullarT et al.

    Time to stop counting the tablets?

    Clin Pharmacol Ther

    (1989)
  • GregoireJ-P et al.

    Measurement of noncompliance to antihypertensive medication using pill counts and pharmacy records

    J Soc Adm Pharm

    (1998)
  • FeinsteinAR

    On whitecoat effects and the electronic monitoring of compliance

    Arch Intern Med

    (1990)
  • CramerJA et al.

    Compliance declines between clinic visits

    Arch Intern Med

    (1990)
  • DirksJF et al.

    Nondichotomous patterns of medication usage: The yes-no fallacy

    Clin Pharmacol Ther

    (1982)
  • StrakaRJ et al.

    Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug

    Pharmacotherapy

    (1997)
  • Cited by (697)

    View all citing articles on Scopus
    View full text